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ABSTRACT 
Objective: To study the intergenus protoplast fusion bioactive marine Streptomyces sp ANS4 with the Escherichia coli for the strain improvement.  
Methods: Protoplast of both the organisms was prepared by lysozyme treatment and fused using polyethylene glycol (PEG). Fusant colonies were 
regenerated using regeneration medium where all the regenerated colonies are powdery in consistency. Microscopic, cultural, physiological, 
enzymatic and antibiotic susceptibility characteristics of one fusant culture and both the parent cultures are studied. Growth curve and bioactive 
metabolite production by both the parent and fusant cultures was also studied. 
Results: oval shaped protoplasts of both the parent cultures are clearly seen under the phase contrast microscope. All the colonies developed after 
protoplast fusion on regeneration medium looked like one of the parent culture Streptomyces sp ANS4. One among the 10 antagonistic colonies 
selected from the regeneration medium was expressed the characteristics of either or both of the parental cultures and certain new characteristics. 
The results of growth curve study showed that the fusant culture possess 10 hours reduction in attaining stationary phase compared to parent 
Streptomyces sp ANS4. The antibiotic activity of fusant culture was also higher than the parent cultures.  
Conclusion: The intergenus protoplast fusion between the Streptomyces sp ANS4 and the E.coli strain results in the reduction in time for secondary 
metabolite production and also increase in antimicrobial activity. This suggested that the potential bioactive compounds may be obtained in 
increased quantity from the fusant culture with lesser fermentation period.  
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INTRODUCTION 
Actinomycetes are virtually unlimited sources of novel compounds 
with many therapeutic applications and hold a prominent position 
due to their diversity and proven ability to produce novel bioactive 
compounds [1]. Traditionally, these bacteria have been isolated from 
terrestrial sources, although the first report of mycelium-forming 
actinomycete from the marine sediments appeared several decades 
ago [2]. The actinomycetes are active components of marine 
microbial communities [3] and form stable, persistent populations in 
various marine ecosystems. Marine actinobacteria are the best 
sources of secondary metabolites and the vast majority of these 
compounds are derived from the single genus Streptomyces, whose 
species are distributed widely in the marine and terrestrial habitats 
and are of commercial interest due to their unique capacity to 
produce novel metabolites [4].  
Various methods of genetic manipulation enable the microbial 
geneticists to create new combinations of genetic material in 
microbes. The genetic manipulation techniques such as inducing 
mutation, protoplast fusion, gene amplification, recombinant DNA 
technology etc., are used in the field of microbiology. Protoplast 
fusion is an efficient method among the various genetic 
manipulation approaches to induce a high frequency of 
recombination [5].  
Protoplast fusion is accomplished by removing the cell walls of 
organisms of two strains and mixing the resulting protoplasts. This 
allows the fusion of the cell and genetic material before new cell wall 
is produced. By mixing two strains, each of which has desirable 
characteristics, the new strains that have both characteristics can be 
produced. After protoplast fusion, some organisms are probably fast 
growing with good producers of the substances. A 200-10,000-fold 
increase in recombination frequency is obtained through protoplast 
fusion when compared to other conventional mating procedures [6].  
As noted, the fusion technique may provide improvement of an 
antibiotic producing strain or by the gene recombination involving 
interspecific fusion leads to the production of novel antibiotics [7]. 
Studies on interspecies mating were initiated in recent years to 
apply genetic recombination technique to the isolation of hybrid 
strains producing new antibiotics.  
The ability of the hybrid strains producing new antibiotic will 
depend in part on proper choice of mating pair, and selective 
procedures imposed during regeneration [6]. Even though there are 
some reports available on the intraspecific fusion, but there are no 
reports available on the intergenus fusion with actinomycetes.  
During the course of our antimicrobial screening program, we 
isolated an actinomycete, Streptomyces sp ANS4 from Andaman 
marine sediments. Crude extract prepared from this strain showed 
promising activity against Gram positive and Gram negative 
bacterial pathogens. In this present study, we report the first 
successful intergenus fusion between actinomycete and eubacteria 
and how the parental characters are distributed in fusant. 
MATERIALS AND METHODS 
Description of Streptomyces sp ANS4 and Escherichia coli 
Streptomyces sp ANS4 was isolated from sediment samples collected 
from Andaman marine ecosystem using starch casein agar [8]. This 
strain produced small powdery colonies with grayish aerial 
mycelium on ISP2 agar medium. Both non-fragmented aerial and 
substrate mycelium was observed under bright field microscope. 
Strain ANS4 showed promising antibacterial activity against Gram 
positive and Gram negative bacteria. Viability of strain ANS4 is 
maintained on ISP2 agar slants [9] as well as in 20% glycerol broth. 
Another parent culture E. coli was isolated from sewage sample. 
Viability of E. coli is maintained as slant culture and stab culture 
using nutrient agar medium.  
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Preparation of parent cultures 
Spores of Streptomyces sp ANS4 from ISP2 agar medium was 
inoculated in to 100 ml of medium S (gm/l: glucose 10; peptone 4; 
yeast extract 4; MgSo4 0.5; KH2Po4 2; K2HPo4) for 48 hours at 280C 
in rotary shaker. The cells were collected and further transferred 
into medium “S” supplemented with 0.8% glycine. The flask was once 
again kept at 280C in rotary shaker until the middle of the exponential 
phase. Finally, the mycelium was harvested by centrifugation and 
washed with a solution of 0.3M sucrose solution [10].  Another parent 
strain, E. coli was grown on LB broth (gm/l: tryptone 10; yeast 
extract 5; sodium chloride 10). After sterilization, 10µg/ml of filter 
sterilized chloramphenicol was added from a stock solution (34 
mg/ml in absolute alcohol) for the inhibition of protein synthesis 
[11]. After 24 hours of incubation, the cells were recovered by 
centrifugation at 3000 rpm for 10 minutes at 4o
For the preparation of protoplasts, Streptomyces sp ANS4 harvested 
from medium ‘S’ was transferred into medium ‘P’ (gm/l sucrose 103; 
potassium sulphate 0.25; trace element solution 2 ml; K2HPo4 0.05; 
MgCl2 2.03; CaCl2 3.68; and 0.25M TES buffer 100 ml) and incubated 
for 2 hours [10]. Lysozyme was added in the final concentration of 1 
mg/ml of medium ‘P’ and incubated at 32
C. 
Preparation of protoplasts  
oC for 2 hours. Then the 
suspension was filtered through cotton and then through Wattman 
paper having 5 µm pore size to exclude mycelial forms. The filtered 
protoplasts were washed three times with cold medium ‘P’ by means 
of centrifugation at 1000 rpm for 15 minutes. The pellet of E. coli 
was obtained from LB medium and resuspended in 2.5ml of ice-cold 
solution of 20% (w/v) sucrose in 50mm Tris-Cl (pH 8.0). Five 
hundred microlitre of fresh lysozyme solution (5mg/ml in 250 mM 
Tris-Cl pH 8.0) was added. The suspension was incubated at 4oC for 
5 minutes. Again 1ml of ice-cold solution of 0.25M EDTA (pH 8.0) 
was added to the above mixture and incubated on ice for 5 minutes. 
Finally 1 ml of ice-cold 50 mM Tris-Cl was slowly added and the 
suspension was incubated at 37o
Fusion of parental protoplasts & regeneration 
C for 15 minutes [11]. 
About 500 µl of protoplast suspension from each parental strain was 
mixed and centrifuged. The pellet was resuspended in 0.1ml of 
medium ‘P’ and mixed with 0.9 ml of 50% (w/v) filter sterilized poly 
ethylene glycol 400 (PEG 400) in medium ‘P’. The suspension was 
allowed to stand 30 seconds for the fusion of protoplasts [12]. The 
fused protoplasts were diluted with medium ‘P’ and 0.05ml of the 
dilution was spread on a regeneration (R2) medium (gm/l sucrose 
103; potassium sulphate 0.25; trace element solution 2 ml; K2HPo4 
0.05; MgCl2 10.12; CaCl2 2.95; glucose 10; L-proline 3; 
casaminoacids 0.1; agar 22; 0.25M TES buffer 100 ml; pH 7.0) plates 
and incubated at 28o
 
C [10]. After enumerating the colonies the 
fusant cultures were randomly selected and streaked on ISP2 
medium for further studies. One fusant culture was selected for 
characterization. 
Table 1: Properties of parent and fusant cultures 
Characteristics Parent cultures Fusant culture 
Streptomyces sp ANS4 E. coli 
Colony morphology Gray colour powdery colonies Colourless Mucoid colonies Gray colour powdery colonies 
Micromorphology Filamentous Rod shaped Filamentous 
Aerial and substrate mycelium Present - Present 
Antibiotic sensitivity    
Penicillin S S R 
Ampicillin S S S 
Chloramphenicol S S R 
Gentamycin S S R 
Enzyme activity    
Amylase + + + 
Protease + + + 
Lipase + + + 
Nitrate reduction - + + 
Gelatin liquefaction + + + 
Melanin production + - + 
Carbon utilization    
Glucose + + + 
Fructose + - + 
Sucrose + + + 
Inositol - + + 
Mannitol -  + 
Rhamnose - + + 
Biomass quantity (gm/200 ml)    
Wet weight 10.30 3.20 21.50 
Dry weight 2.80 1.05 5.10 
Quantity of Ethyl acetate extract (mg/200 ml) 25 12 40 
Antimicrobial activity*    
Methicillin resistant Staphylococcus aureus 12.3±0.57 - 13.3±0.58 
Staphylococcus aureus 10.3±0.58 - 10.3±0.57 
Bacillus subtilis 14.7±0.58 - 13.3±1.15 
Escherichia coli 8.0±1.0 8.3±0.58 - 
Salmonella typhi 9.7±0.57 - 10.3±0.59 
Vibrio cholerae 6.7±0.58 - 10.7±0.57 
 S – sensitive; R – resistant; * Zone of Inhibition represented with mean ± standard deviation (n = 3). 
 
Characterization of fusant and parent cultures 
Cultural, microscopic and carbon utilization characteristics of fusant 
and Streptomyces sp ANS4 was studied by adopting the method 
described by Shirling and Gottileb [9] whereas the same 
characteristics of E. coli were studied by adopting the standard 
microbiological procedures.  
The antibiotic susceptibility of Streptomyces sp ANS4 and fusant culture 
was determined on ISP2 agar plates whereas antibiotic susceptibility of 
E. coli was determined using Muller Hinton agar [13]. Antibiotic discs 
(Himedia) used for this includes chloramphenicol, penicillin, gentamycin 
and ampicillin. Zone of inhibition was measured after 48 hours and 
expressed in millimeter in diameter.  
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The parental and fusant cultures were tested for the enzyme 
activities such as amylase, protease and lipase using starch agar, 
skim milk agar and Tween 80 agar, respectively. All the plates were 
incubated at 28o
Growth curve studies 
C for 3 days. After incubation, the amylase activity 
was observed by adding iodine solution; protease activity was 
observed directly by zone of clearance whereas the lipase activity 
was determined by opaque zone around the colonies [14]. 
Hundred ml of LB medium was inoculated with 10ml of one-hour 
culture of E. coli and each 100 ml of sporulation medium was 
inoculated with 10ml of Streptomyces sp and fusant culture grown 
on ISP2 medium. Then the flasks were kept in rotary shaker at 28o
Production of bioactive metabolites 
C. 
The OD value was measured for every 2 hours in a 
spectrophotometer at 550nm. Uninoculated medium was used as a 
blank [15]. The OD value was taken for Streptomyces sp and fusant 
cultures between 0 and 120 hours and between 0 and 40 hours for E. 
coli.  
The parent strain Streptomyces sp ANS4 and the fusant culture were 
grown on ISP2 agar for 5 days at 280C. The spores were collected 
using 20% sterile Tween 80 solution. The collected spores were 
transferred into each 50ml of soybean meal inoculation medium and 
kept in rotary shaker for 48 hours at 280C. Then 10% of inoculum 
was added to the soybean meal production medium. The culture 
broths of production medium were centrifuged separately at 6,000 
rpm for 20 minutes at 40C and the resultant cell free supernatant 
was used for the extraction of bioactive compounds. The mycelial 
cake was collected and weighed to determine total biomass. The 
fermentation broth was extracted with ethyl acetate in pH levels of 
4,7 and 10 and concentrated. About 250 microgram of crude extract 
was impregnated on the filter paper disc and tested against different 
clinical bacterial pathogens by disc diffusion method. Zone of 
inhibition was measured after 24 hours of incubation at 370
RESULTS AND DISCUSSION 
C and 
expressed in millimeter in diameter [8]. 
Protoplast preparation, fusion and regeneration 
The first work on the protoplast fusion of Streptomyces using poly 
ethylene glycol (PEG) was reported by Hopwood et al. [16] and 
recombination frequencies achieved by this technique are so high 
that selectable marker could be dispensed with at least in certain 
kinds of strain improvement programmes. In the present study, the 
efficient formation of protoplast of Streptomyces sp and E. coli was 
confirmed by roundness of the cells. Okanishi et al. [10] have 
demonstrated that S. griseus and S. venezulae become highly 
sensitive to enzymatic hydrolysis by lysozyme and lytic enzyme No. 
2 after the growth in a medium containing a partially growth-
inhibitory concentration of glycine. Baltz [12] also found that 
lysozyme treatment was effective on fusion of S. fradiae and S. 
griseofuscus protoplasts. The effect of lysozyme in the present study 
was found satisfactory with the successful isolation of protoplasts.  
The effective protoplast fusion among various species of 
Streptomyces was achieved using 40 to 60% PEG for 30-60 seconds 
at 230C (Baltz, 1981; Ochi et al., 1979; Hopwood and Wright 
1981)[7,17,18]. Imada et al. [5] achieved intergenus protoplast 
fusion between Streptomyces and Micromonospora using 40% PEG 
for 3 minutes at room temperature. In the present study, the fusion 
was undertaken by using 50% PEG (w/v) and good result was 
obtained. The effect of Mg2+ and Ca2+ on the stabilization of 
protoplast was described. The Mg2+ prevents the release of lipid 
residues from plasma membrane and controlling the liberation of 
mesosome vesicles from protoplast during the removal of cell wall 
by lysozyme. The Ca2+ prevents the lysis of lysozyme-induced 
protoplast in hypertonic medium. The combinations of 10mM-MgCl2 
and 25mM-CaCl2
In this study the first visible colonies appeared from regeneration 
medium after 4 days of incubation, while the last appeared on 10 
days of incubation. The process of cell regeneration from protoplast 
was generally slow and asynchronous. In this intergenus 
experiment, there are about 147 colonies were appeared and almost 
all the fusants resemble Streptomycete colonies in cultural and 
micromorphology. Among 147 total colonies, 10 colonies were 
randomly selected based on their morphological differences. Imada 
et al. [5] also suggested that the protoplast fusion technique would 
be promising for obtaining new clones through intergenus 
protoplast fusion. Among these 10 colonies, only one colony was 
selected for further characterization based on the bioactivity. 
 was effective for preparing and stabilizing the 
protoplasts of streptomycete in hypertonic solutions was reported 
by Okanishi et al. [10] as like in the present study.  
Characterization of parent and fusant cultures 
The morphology and spore arrangements of fusant was found 
similar to the parent Streptomyces sp ANS4 when observed under 
bright field microscope. In antibiotic sensitivity testing, both 
parental culture of Streptomyces sp ANS4 and E. coli was found 
sensitive to the antibiotics penicillin, gentamycin, choloramphenicol 
and ampicillin. Whereas the fusant culture showed resistance to the 
penicillin, chloramphenicol and ampicillin. It is also observed that 
the fusant culture was found sensitive to gentamycin (Table 1). It 
was already mentioned that protoplast fusion technique may result 
in expression of new protein, which is not expressed in either 
parental strains [19]. In the present study also the fusant culture, 
showed resistant to penicillin chloramphenicol and ampicillin but 
neither of the parents showed this resistance. It is discussed that the 
genes responsible for resistance were already present in any one of 
the parents but under strict regulation. The fusion might have 
inactivated one or more regulatory genes and resulted in newly 
found resistance character in fusant. 
All the cultures of both parent as well as fusant cultures showed 
positive to all the enzyme activities tested viz. amylase, protease and 
lipase. So there is no change among enzyme activities. The parent 
strain of Streptomyces sp showed negative result for nitrate 
reduction test but the fusant showed positive as in E. coli. It clearly 
demonstrates that the gene coding for nitrate reduction was 
transferred to fusant and successfully expressed in it (Table 1). Both 
the parents and fusant cultures were found to exhibit gelatin 
liquefaction. Both the parent Streptomyces sp ANS4 and fusant 
culture was found to produce melanin. The melanin pigment 
production was observed in Streptomyces sp but not in fusant and E. 
coli. It may be attributed to alteration in Streptomyces genome by 
recombination or deletion or blocking of genes responsible for 
melanin production during fusion. 
By using glucose as a positive control of carbon source, the following 
results were observed. The Streptomyces sp utilizes sucrose, and 
fructose, and E. coli utilizes sucrose, inositol and rhamnose. But the 
fusant culture utilizes mannitol, sucrose, fructose, inositol and 
rhamnose. It was observed that fusant possessed enhanced 
capabilities of degrading sugars as their sole source of carbon when 
compared to parental strains. The fusant was found to be utilizing all 
the 6 sugars tested, while the capability of parent strain 
Streptomyces sp was 3 and E. coli was 4 and none of them utilized 
raffinose. E. coli can degrade inositol and rhamnose but not 
Streptomyces sp. But the fusant can degrade both sugars. It shows 
that E.coli provides the genes responsible for utilization of these 
sugars and successfully expressed in fusant. In the case of mannitol 
neither of parental strains can utilize it but the fusant efficiently 
utilizes the mannitol (Table 1). It may be due to inactivation of one 
or more regulatory proteins that resulted in expression of genes 
responsible for degradation of mannitol. 
Growth curve studies 
From the growth curve studies it was observed that there are about 10 
hours of reduction in growth time of fusant culture. In Streptomyces sp 
the stationary phase attained at 68 hours but in fusant it was at 58 
hours. The stationary phase of E. coli was found at 23 hours of 
incubation. It is concluded that the fusant culture showed maximum 
growth between 68 and 23 hours. During the studies of growth factors 
of parental and fusant culture strains, we observe that the growth 
characteristics of fusant were similar to Streptomyces sp but the time 
of reaching stationary phase was significantly reduced. There is a 
possibility that the cell cycle components of Streptomyces sp 
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responding to cyclins and kinases encoded by E.coli genome. The 
mixing of cell cycle components from two different genera with 
different growth kinetics might have resulted in intermediate growth 
kinetic properties. This theory correlates properly with the readings 
found in the present experiment i.e., E. coli at 22 hours, Streptomyces 
sp at 68 hours and fusant 58 at hours. 
Isolation of bioactive compound 
The supernatant and mycelial pellet of parent and fusant cultures from 
production medium were collected for further analysis. The result 
showed that fusant culture was produced double the biomass when 
compared to parental culture. Ethyl acetate extract prepared from the 
supernatants of parent and fusant cultures were taken for total 
quantity of bioactive compounds and activity against various clinical 
pathogens. About 40 and 25 mg of crude extract were obtained from 
the cell free supernatant of fusant culture and Streptomyces sp ANS4, 
respectively using ethyl acetate. The results showed that the fusant 
extract having wide spectral activity against both Gram positive and 
Gram negative bacteria in addition to MRSA strain. One particular 
point of interest in this study was the antagonistic activity of fusant 
against methicillin resistant Staphylococcus aureus (MRSA) while 
parental Streptomyces sp cannot show such inhibition effect on MRSA 
(Table 1). It may be due to alteration in secondary metabolite 
production in fusant or may attributed to modification made by E. coli 
encoding enzymes in the structure of bioactive substance encoded by 
Streptomyces sp which resulted in novel bioactive substance.  
In the present study we have successfully isolated a fusant strain by 
protoplast fusion with the faster growth rate than parental strain 
with high antibiotic activity especially against MRSA. As effective 
antibiotics are not available nowadays to treat the disease caused by 
MRSA strains, this fusant culture obtained from the present study 
may be a good source for isolating more effective antibiotics with 
short fermentation time compared to wild strains. 
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